Quote

If you look at the world's top 50 drugs being sold today, they are being marketed and sold by companies that did not invent them. I respect patents. I'll pay a royalty. But I shouldn't be denied the right to produce drugs for poor people at reasonable prices.

I believe that life-saving, essential drugs should be freely available and the innovator should be paid a suitable royalty payment for his invention.

I keep encouraging the pharmaceutical companies to put more money into R&D.

When in some communities selling drugs is so lucrative that that's a pretty big enticement that we have to break down. Part of that is by making opportunities and paying decent wages.

The War on Drugs employs millions - politicians, bureaucrats, policemen, and now the military - that probably couldn't find a place for their dubious talents in a free market, unless they were to sell pencils from a tin cup on street corners.

It's more important to try to do something for the crores of poor people of my country.

Would-be drug companies must either produce medicines that stand up to federal scrutiny, demonstrate that their data has value to other companies, or go out of business.

If you earned money listening to music, I'd be a millionaire.

It doesn't matter if you have one billion rupees in your bank account or one rupee. This is one life you get, and you'd rather spend it enjoying whatever you have, rather than thinking, 'Oh, I should have scored seven more runs, or I should get more money.'

Cadila, India's sixth-largest drugmaker by sales, spent $250 million developing Lipaglyn, a new chemical entity or new discovery, and aims to spend another $150 million to $200 million to launch the drug outside India.